The global lipid nanoparticles (LNP) contract development and manufacturing organization (CDMO) market is poised for substantial double-digit growth by 2027, driven by the growing acceptance of LNPs ...

Scientists from Tel Aviv University and the Israel Institute of Biological Research say their vaccine uses lipid ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Utrecht University researchers Bas van Ravensteijn and Markus Weingarth have each been awarded an ERC Proof of Concept Grant of €150.000 to further enhance antibiotics and nanomedice ...

For decades, the dream of fixing harmful mutations in mitochondrial DNA felt out of reach. Scientists have long known these ...

Ticks and the diseases they carry are only becoming more common. But new treatments and vaccines might not be too far off.

Scientists in Tel Aviv and IIBR have developed an mRNA vaccine. It combats the deadly Yersinia pestis bacterium. This bacterium causes plague. The vaccine showed 100% effectiveness in animal trials.

Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...

University of Osaka researchers used genome editing to program mouse liver cells to produce exenatide, a weight-loss drug.

Ben Hargreaves speaks to Liberate Bio, a company that is hoping to address the delivery issues that could prevent mRNA, as well as siRNA and ASO therapeutics, from reaching their full potential.